Venous thromboembolic complications after kidney and kidney-pancreas transplantation: A multivariate analysis

Transplantation

Volumn 65, Issue 2, 1998, Pages 229-234

  Humar, A ^a   Johnson, E M ^b   Gillingham, K J ^b   Sutherland, D E ^b   Payne, W D ^b   Dunn, D L ^b   Wrenshall, L E ^b   Najarian, J S ^b   Gruessner, R W ^b   Matas, A J ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; AZATHIOPRINE; CYCLOSPORIN; HEPARIN; LYMPHOCYTE ANTIBODY; PREDNISONE; WARFARIN;

ANGIOGRAPHY; ANTICOAGULATION; ARTICLE; COMPRESSION THERAPY; DEEP VEIN THROMBOSIS; DOPPLER ECHOGRAPHY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY TRANSPLANTATION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PANCREAS TRANSPLANTATION; PHLEBOGRAPHY; PRIORITY JOURNAL; RISK FACTOR; VENA CAVA FILTER;

EID: 0032570301     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199801270-00015     Document Type: Article

References (30)

1. Clagett GP, Anderson FA Jr, Levine MN, et al. Prevention of venous thromboembolism. Chest 1992; 102: 3915.
2. Oster G, Tuden RL, Colditz GA. Prevention of venous thrombosis after general surgery: cost-effectiveness analysis of alternative approaches to prophylaxis. Am J Surg 1987; 82: 889.
3. Clagett GP, Reisch JS. Prevention of venous thrombosis in general surgical patients: results of meta-analysis. Ann Surg 1988; 208: 227.
4. NIH Consensus Development. Prevention of venous thrombosis and pulmonary embolism. JAMA 1986; 256: 744.
5. Arnadoltir M, Bergentz SE, Bergquist D, et al. Thromboembolic complications after renal transplantation: a retrospective analysis. World J Surg 1983; 7: 757.
6. Advisory Committee to the Renal Transplant Registry. The 12th report of the Human Renal Transplant Registry JAMA 1975; 233: 787.
7. European Dialysis and Transplant Association. Combined report on regular dialysis and transplantation in Europe London: Pitman, 1983: 13.
8. Schweitzer EJ, Matas AJ, Gillingham KJ, Payne WD. Causes of renal allograft loss: progress in the 1980s, challenges for the 1990s. Ann Surg 1991; 214: 679.
9. Troppmann C, Gillingham KJ, Benedetti E, et al. Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. Transplantation 1995; 59: 962.
10. Gruessner RWG, Sutherland DER. Pancreas transplantation. Part II: the recipient operation. Surg Rounds 1994; 17: 383.
11. Berquist D, Bergentz SE, Bornmyr S, et al. Deep venous thrombosis after renal transplantation. Eur Surg Res 1985; 17: 69.
12. Allen RD, Mite CA, Moor JA, Morris PJ. Deep venous thrombosis after renal transplantation. Surg Gynecol Obstet 1987; 164: 137.
13. Vanrenterghem M, Roels L, Lerut T, et al. Thromboembolic complications and hemostatic changes in cyclosporin-treated cadaveric kidney allograft recipients. Lancet 1985; 1: 999.
14. Rao KV, Smith EJ, Alexander JW, et al. Thromboembolic disease in renal allograft recipients. Arch Surg 1976; 111: 1086.
15. Gruber SA, Pescovitz MD, Simmons RL, et al. Thromboembolic complications in renal allograft recipients. Transplantation 1987; 44: 775.
16. Samama MM, Simonneau G, Wainstein JP, et al. SIRIUS study: epidemiology of risk factors of DVT of the lower limbs in community practice [Abstract]. Thromb Haemost 1993; 69: 763.
17. Brunkwall J, Berggvist D, Bergentz SE, et al. Postoperative deep venous thrombosis after renal transplantation: effects of cyclosporine. Transplantation 1987; 43: 647.
18. Leitha T, Graninger W, Zazgornik J. Cyclosporine A does no increase the frequency of thromboembolic events. Transplan Proc 1988; 20: 436.
19. Brewster DC. Introduction to symposium on transvenous cava interruption. J Vasc Surg 1984; 1: 487.
20. Donaldson GA, Williams C, Scannell JG, et al. A reappraisal of the application of the Trendelenburg operation to massive pulmonary embolism: a report of a successful pulmonary-artery thrombectomy using a cardiopulmonary bypass N Eng J Med 1963; 268: 171.
21. Rohrer MJ, Scheidler MG, Brownell Wheeler H, et al. Extended indications for placement of an inferior vena cava filter. J Vasc Surg 1989; 10: 44.
22. Browse NL, Thomas ML. Source of nonlethal pulmonary emboli Lancet 1974; 1: 258.
23. Pasquale MD, Abrams JH, Najarian JS, Cerra FB. Use of Greenfield filters in transplant patients: are they safe? Transplantation 1992; 55(2): 439.
24. Hull RD, Raskob GE, Hirsh J. Prophylaxis of venous thromboembolism: an overview. Chest 1986; 89: 374S.
25. Collins R, Scrimgeour A, Yusuf S, et al. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin: overview of results of randomized trials in general, orthopedic, and urologic surgery N Engl J Med 1988; 318: 1162.
26. Ubhi CS, Lam FT, Mavor AID, Giles GR. Subcutaneous heparin therapy for cyclosporine-immunosuppressed renal allograft recipients. Transplantation 1989; 48: 886.
27. Green D, Hirsh J, Heit J, et al. Low molecular weight heparin: a critical analysis of clinical trials. Pharmacol Rev 1994; 46: 89.
28. Anderson FA, Wheeler HB. Venous thromboembolism: risk factors and prophylaxis. Clinics Chest Med 1995; 16: 235.
29. European Consensus Statement (1-5 November, 1991). Prevention of venous thromboembolism. Int Angiol 1992; 11: 151.
30. Planes A, Vochelle N, Darmon JY, et al. Risk of deep venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomized comparison of enoxaparin versus placebo. Lancet 1996; 348: 224.